2014
DOI: 10.1016/j.bbapap.2013.08.002
|View full text |Cite
|
Sign up to set email alerts
|

Briefing in family characteristics of microRNAs and their applications in cancer research

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
27
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(27 citation statements)
references
References 60 publications
0
27
0
Order By: Relevance
“…Furthermore, gene expression profiling was used to classify paediatric ALL subtypes by Yeoh et al [3]. Recently, apart from microarray technology for questions such as AML subtype determination [4], interest has been also turned towards searching for leukaemia biomarkers with miRNA [510] and lncRNA [11] analysis. Despite the existence of all those studies, there remains only one exceptional study which was conducted on a large scale to discriminate between all of the leukaemia subtypes [12].…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, gene expression profiling was used to classify paediatric ALL subtypes by Yeoh et al [3]. Recently, apart from microarray technology for questions such as AML subtype determination [4], interest has been also turned towards searching for leukaemia biomarkers with miRNA [510] and lncRNA [11] analysis. Despite the existence of all those studies, there remains only one exceptional study which was conducted on a large scale to discriminate between all of the leukaemia subtypes [12].…”
Section: Introductionmentioning
confidence: 99%
“…Sixty-five percent of all miRNAs are part of multimember families (Wang et al 2014). Many of the miRNA families in humans regulate targets relevant for development and disease.…”
mentioning
confidence: 99%
“…Onco‐miRNAs are usually highly expressed in tumor cells and promote the development and progression of the tumor. In contrast, tumor‐suppressor miRNAs are often downregulated or absent in tumor cells, and they suppress tumor growth . In recent years, miRNAs have been considered a novel therapeutic target for cancer .…”
Section: Introductionmentioning
confidence: 99%
“…In contrast, tumor-suppressor miRNAs are often downregulated or absent in tumor cells, and they suppress tumor growth. 3,7 In recent years, miRNAs have been considered a novel therapeutic target for cancer. 8,9 These strategies include interfering with onco-miRNAs to suppress tumor growth and importing exogenous tumor-suppressor miRNAs into tumor cells to treat cancer.…”
Section: Introductionmentioning
confidence: 99%